
Vera’s Trutakna Drug Gets FDA Approval For Primary IgA Nephropathy
In a major milestone for chronic kidney disease treatment, Vera’s Trutakna drug gets FDA approval as a weekly injectable kidney
In a major milestone for chronic kidney disease treatment, Vera’s Trutakna drug gets FDA approval as a weekly injectable kidney drug. Manufactured …
In a breakthrough in early endometriosis diagnosis, researchers from the University of Edinburgh have identified hormone biomarkers that can detect endometriosis with …
Vertex Pharmaceuticals has announced a definitive agreement to acquire Crinetics Pharmaceuticals for approximately $10 billion, the company’s largest acquisition ever. This massive …
The Swiss pharmaceutical giant Novartis has officially agreed to acquire UK-based biotechnology firm Myricx Bio. The Novartis Myricx Bio acquisition is valued …
The daily Wegovy weight loss pill in UK pharmacies is now officially available through private channels following its recent regulatory clearance. The …
A recent Legionnaires’ disease outbreak in NYC has now escalated to 14 confirmed cases, up from just two cases reported early last …
The biotechnology leader Insilico Medicine announced a major strategic collaboration with global pharmaceutical giant Takeda. This Insilico Medicine Takeda partnership aims to …
The U.S. Food and Drug Administration (FDA) has officially upgraded the voluntary Utz potato chip recall to the highest risk level with …
The Australian Competition and Consumer Commission (ACCC) has taken decisive enforcement action against Lactalis Australia Pty Ltd, a major player in the …
The U.S. Food and Drug Administration (FDA) has officially approved Orca Bio’s groundbreaking cell therapy, Tregzi (also known as Orca-T). It is …
Anthropic has officially announced the launch of Claude Science, an advanced platform designed to accelerate global health innovations. Claude Science by Anthropic …
Ipsen, the biopharmaceutical company, recently announced a definitive merger agreement to acquire Kartos Therapeutics. Under this Ipsen Kartos Therapeutics Acquisition, the French …

In a major milestone for chronic kidney disease treatment, Vera’s Trutakna drug gets FDA approval as a weekly injectable kidney

In a breakthrough in early endometriosis diagnosis, researchers from the University of Edinburgh have identified hormone biomarkers that can detect

Vertex Pharmaceuticals has announced a definitive agreement to acquire Crinetics Pharmaceuticals for approximately $10 billion, the company’s largest acquisition ever.

The Swiss pharmaceutical giant Novartis has officially agreed to acquire UK-based biotechnology firm Myricx Bio. The Novartis Myricx Bio acquisition

The daily Wegovy weight loss pill in UK pharmacies is now officially available through private channels following its recent regulatory

A recent Legionnaires’ disease outbreak in NYC has now escalated to 14 confirmed cases, up from just two cases reported

The biotechnology leader Insilico Medicine announced a major strategic collaboration with global pharmaceutical giant Takeda. This Insilico Medicine Takeda partnership

The U.S. Food and Drug Administration (FDA) has officially upgraded the voluntary Utz potato chip recall to the highest risk

The Australian Competition and Consumer Commission (ACCC) has taken decisive enforcement action against Lactalis Australia Pty Ltd, a major player

The U.S. Food and Drug Administration (FDA) has officially approved Orca Bio’s groundbreaking cell therapy, Tregzi (also known as Orca-T).

Anthropic has officially announced the launch of Claude Science, an advanced platform designed to accelerate global health innovations. Claude Science

Ipsen, the biopharmaceutical company, recently announced a definitive merger agreement to acquire Kartos Therapeutics. Under this Ipsen Kartos Therapeutics Acquisition,